Market10 years ago
News Review: Kandi Technolgies Group Inc (NASDAQ:KNDI), Exelixis, Inc. (NASDAQ:EXEL), URS Corporation (NYSE:URS)
Exelixis, Inc. (NASDAQ:EXEL)’s shares increased 8.87% to $3.62. The company on July 13 announced positive top-line results from coBRIM, the phase 3 pivotal trial evaluating cobimetinib,...